You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 245 Development and application of physiologically based pharmacokinetic – pharmacodynamic (PBPK-PD) model for dose optimization of TAK-102: GPC3 targeted CAR-T armored with IL-7 and CCL-19

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Cellular Therapies
245 Development and application of physiologically based pharmacokinetic – pharmacodynamic (PBPK-PD) model for dose optimization of TAK-102: GPC3 targeted CAR-T armored with IL-7 and CCL-19

 

Online download statistics by month:

Online download statistics by month: November 2023 to June 2025

AbstractFullPdf
Nov 2023316037
Dec 20236706
Jan 20245604
Feb 20243404
Mar 20245408
Apr 20244804
May 20246004
Jun 20245006
Jul 20245802
Aug 20243605
Sep 20242801
Oct 20244207
Nov 20244807
Dec 20244609
Jan 202538017
Feb 2025206
Mar 2025004
Apr 2025008
May 2025007
Jun 2025008
Total9830154